Results 41 to 50 of about 6,579 (240)

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma [PDF]

open access: yes, 2015
published_or_final_versio
Kwong, DLW   +9 more
core   +1 more source

Side Effects of Yttrium-90 Radioembolization

open access: yesFrontiers in Oncology, 2014
Limited therapeutic options are available for hepatic malignancies. Image guided targeted therapies have established their role in management of primary and secondary hepatic malignancies.
Ahsun eRiaz, Rafia eAwais, Riad eSalem
doaj   +1 more source

Metastatic breast cancer from a hepatocellular carcinoma: a case report [PDF]

open access: yesKorean Journal of Clinical Oncology, 2022
Breast metastases from extramammary malignancies are rare. Here, we report a case of breast metastasis from hepatocellular carcinoma (HCC) after breast mass excision in a 63-year-old woman.
Hyewon Bang   +6 more
doaj   +1 more source

Single injection dual phase CBCT technique ameliorates results of trans-arterial chemoembolization for hepatocellular cancer [PDF]

open access: yes, 2017
Cone-beam CT (CBCT) application to the field of trans-arterial chemoembolization has been recently the focus of several researches. This imaging modality is performed with a rotation of the C-arm around the patient, without needs of patient repositioning.
Argirã², Renato   +6 more
core   +1 more source

Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection [PDF]

open access: yes, 2014
Introduction: For patients with resectable hepatocellular carcinoma (HCC), hepatectomy remains one of the best treatment options to provide long-term survival.
Chan, ACY   +10 more
core   +1 more source

Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol

open access: yesBMC Cancer, 2023
Background High dose unilobar radioembolization (also termed ‘radiation lobectomy’)—the transarterial unilobar infusion of radioactive microspheres as a means of controlling tumour growth while concomitantly inducing future liver remnant hypertrophy—has ...
Daan Andel   +19 more
doaj   +1 more source

Polyethylene Glycol Epirubicin-Loaded Transcatheter Arterial Chemoembolization Procedures Utilizing a Combined Approach with 100 and 200 μm Microspheres: A Promising Alternative to Current Standards [PDF]

open access: yes, 2019
PURPOSE:To report clinical effectiveness, toxicity profile, and prognostic factors of combined 100 μm ± 25 and 200 μm ± 50 epirubicin-loaded polyethylene glycol (PEG) microsphere drug-eluting embolic transcatheter arterial chemoembolization protocol in ...
Argirò, Renato   +12 more
core   +1 more source

Ytrrium-90 transarterial radioembolization in patients with gastrointestinal malignancies

open access: yesClinical and Translational Oncology, 2022
Transarterial radioembolization (TARE) with yttrium-90 (Y90) is a promising alternative strategy to treat liver tumors and liver metastasis from colorectal cancer (CRC), as it selectively delivers radioactive isotopes to the tumor via the hepatic artery, sparring surrounding liver tissue. The landscape of TARE indications is constantly evolving.
D. Viñal   +4 more
openaire   +3 more sources

Updated management of malignant biliary tract tumors: an illustrative review [PDF]

open access: yes, 2016
The management of malignant biliary tumors (MBTs) is complex and requires a multidisciplinary approach. Guidelines and methods of staging for biliary tumors have recently been released by main international societies, altering the clinical and radiologic
Cannavale, Alessandro   +6 more
core   +1 more source

Update in management of hepatocellular carcinoma in Eastern population [PDF]

open access: yes, 2015
Hepatocellular carcinoma (HCC) is one of the commonest malignant tumours in the East. Although the management of HCC in the West is mainly based on the Barcelona Clinic for Liver Cancer staging, it is considered too conservative by Asian countries where ...
Cheung, TT, Chu, KK
core   +1 more source

Home - About - Disclaimer - Privacy